- About Health
LAS VEGAS, NV / ACCESSWIRE / October 7, 2020 / Golden Triangle Ventures, Inc. (OTC PINK:TOMI), a strategic consulting company doing business in the Health, Entertainment, and Technology sectors, is pleased to announce a full rollout strategy for its Health Division under its subsidiary, Global Health Services, LLC.
Global Health Services, LLC has a mission to provide solutions to a variety of different businesses in the health sector while maintaining the highest professional standards available. The goal is to help people around the nation with products and services that enhance the world we live in. The company is currently doing business in the CBD space and in the Medical PPE space, which aims to provide an array of products and services for individuals and businesses in both markets. The company is in the process of building an online portal which will position a multitude of verticals on a single platform
MARKHAM, ON, Oct. 6, 2020 /CNW/ – Today, Nielsen Canada announced a strategic alliance with District Ventures, a venture capital fund investing in the food, beverage and health and wellness sectors. District Ventures will gain access to Nielsen’s best-in-class retail universe in support of its investment decisions and its portfolio clients will have access to retail measurement, consumer data and innovation services to help facilitate data driven decisions.
This alliance will empower District Ventures and its portfolio companies to make bold decisions and transform their businesses with trusted data, solutions and insights designed to drive progress. With groundbreaking technology, Nielsen provides a truly complete picture of the complex and changing Canadian marketplace that manufacturers need to innovate and grow their businesses.
“We’re thrilled to be providing support and leadership to District Ventures’ ecosystem and the District Ventures Accelerator Program,” says Richard Lee, VP of Strategic Alliances, North America
The launch of Food Tech Studio – Bites! comes at a time where COVID-19 and the ongoing climate crisis has threatened the global food supply chain and left millions of people around the world without food security and nutrition. In fact, research from The United Nations World Food Programme indicates that more than a quarter of a billion people face the threat of starvation this year as a result of the multiple impacts of COVID-19, crop failure, and climate change.
Food shortages, broken supply chains, changing dietary habits, waste, and health issues have made it imperative to improve livelihoods by building more inclusive, environmentally sustainable, and resilient food systems. Food Tech Studio – Bites! has set out to address these challenges and will give startups unprecedented access to revenue-generating opportunities and decision-makers across the public and private sectors. Recognizing the importance of growth capital, it will also lean into the
Partnership between these two high-touch companies provides clients with scalable solutions to address the changing needs of academic institutions accelerated by COVID-19
Tesseract Ventures, a Kansas City-based technology company helping organizations become smarter, better connected and more efficient through next-generation robotics, 21st century software and radically connected platforms, today announced it has selected Lumen Touch, an all-in-one software provider, as a partner to develop health and wellness programs in K-12 schools and collegiate institutions during the COVID-19 pandemic and beyond.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200929005278/en/
Tesseract Ventures partners with Lumen Touch to provide clients with an accurate tracking system of wearable badges to collect attendance, proximity and wellness data in order to provide real-time results and insights for decision-makers. (Photo: Business Wire)
“We are excited for the opportunity to introduce our next-generation technology as part of Lumen Touch’s Bright Care Solution,” said John Boucard,
SHANGHAI, Sept. 28, 2020 /PRNewswire/ — InventisBio, a clinical stage biotech company dedicated to the research and development of innovative small molecule drugs, announced the recent completion of a $147 million series D financing which has attracted participation of many top biopharmaceutical and healthcare venture capital funds. This round of investment was led by Hillhouse affiliate GL Ventures, followed by Qiming Venture Partners, Janchor, AIHC Capital, Matrix Partner China, Dyee Capital, E Fund Capital and other investors. The existing shareholders including Lilly Asia Venture, OrbiMed Asia, Pudong Innotek, AdvanTech Capital, and CMB International continued their support. China Renaissance was the exclusive financial advisor of this transaction.
Currently InventisBio has three drug products in the mid- to late-stage clinical development, and one new product just entered global phase I clinical study. Among them, D-0502 is an oral selective estrogen receptor degrader (SERD), which also acts as an estrogen
Hairstyle 2020 | All Rights Reserved.
Hairstyle theme by Flythemes